Investigation: The race-based algorithms deciding who gets medical care

Also: Dana-Farber CEO Laurie Glimcher to step down, saying 'we must look to the next generation'

September 3, 2024 Check out STAT+

Sponsored By

Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change? A look at the common use of race in medical decision-making tools, and the difficulty of revising clinical algorithms to reduce bias. By Katie Palmer and Usha Lee McFarling STAT+ | Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition The drug is for cerebral cavernous malformation, a potentially fatal condition that causes brain vessels to become enlarged and irregular By Allison DeAngelis STAT+ | European court sides with Illumina, saying regulators overstepped in scrutiny of Grail deal Illumina has already divested Grail, but it will no longer have to pay a major fine as a result of the court ruling. By Andrew Joseph Christopher Capozziello for STAT STAT+ | Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades Kathy Giusti, a cancer survivor, author of "Fatal to Fearless," and a former pharma exec, has raised $600 million for multiple myeloma research. By Matthew Herper STAT+ | Greece's antitrust regulator probes Novartis over practices tied to a pricey eye drug The company directly harmed the country, competitors, as well as consumers and patients, antitrust officials maintained. By Ed Silverman STAT+ | Vaxcyte shares boom as one of biotech's big David vs. Goliath stories heats up In the small study, the company's vaccine outperformed Pfizer's current version of Prevnar, causing shares to rocket up 36%. By Matthew Herper David L. Ryan/Globe Staff STAT+ | Dana-Farber CEO Laurie Glimcher to step down, saying 'we must look to the next generation' Glimcher's tenure was capped by her surprise split with Dana-Farber's longtime partner, Brigham and Women's Hospital. By Larry Edelman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser